US2021107937A1PendingUtilityA1
Selective enrichment of antibodies
Est. expiryMar 5, 2030(~3.6 yrs left)· nominal 20-yr term from priority
C07K 1/32C07K 14/31
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a process for the selective concentration of immunoglobulins or other proteins that contain an Fc domain (target protein), comprising the following steps: a. preparing a solution that contains the target protein; b. incorporating an Fc-binding protein with precisely two binding sites under conditions that allow binding to occur; c. separating the precipitate from the liquid phase; d. undoing the binding of the target protein from the Fc-binding protein.
Claims
exact text as granted — not AI-modified1 - 9 . (canceled)
10 . Fc-binding protein that consists of 2 identical sub-units that have the sequence SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, or a sequence that differs from SEQ ID NO. 1 in 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 amino acids, wherein the two sub-units are linked together via a covalent bond.
11 . Fc-binding protein according to claim 10 , wherein the covalent bond is a disulphide bond.
12 . Fc-binding protein according to claim 10 , wherein the Fc-binding protein is a dimer of an Fc-binding domain of protein A or protein G.
13 . Fc-binding protein according to claim 12 , wherein the Fc-binding domain comprises or contains one of the sequences SEQ ID NO: 1 to SEQ ID NO: 11.
14 . Fc-binding protein according to claim 12 , wherein the two monomers of the dimer are linked together by a disulphide bridge.
15 . Fc-binding protein according to claim 10 , wherein the dimer is a homodimer, the monomers of which have the sequence SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, or a sequence that differs from SEQ ID NO. 1 in 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 amino acids.Join the waitlist — get patent alerts
Track US2021107937A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.